Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001228986 | SCV001401416 | uncertain significance | Congenital myasthenic syndrome 8 | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004978160 | SCV005572206 | uncertain significance | Inborn genetic diseases | 2024-09-27 | criteria provided, single submitter | clinical testing | The c.5465C>T (p.S1822L) alteration is located in exon 32 (coding exon 32) of the AGRN gene. This alteration results from a C to T substitution at nucleotide position 5465, causing the serine (S) at amino acid position 1822 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |